Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $155.1 million.

  • GeneDx Holdings' Cash & Current Investments rose 3316.07% to $155.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.1 million, marking a year-over-year increase of 3316.07%. This contributed to the annual value of $141.2 million for FY2024, which is 848.03% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Cash & Current Investments is $155.1 million, which was up 3316.07% from $134.6 million recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Cash & Current Investments peaked at $461.3 million during Q3 2021, and registered a low of $26.5 million during Q2 2021.
  • In the last 5 years, GeneDx Holdings' Cash & Current Investments had a median value of $141.2 million in 2024 and averaged $179.1 million.
  • As far as peak fluctuations go, GeneDx Holdings' Cash & Current Investments skyrocketed by 4036355.24% in 2021, and later plummeted by 6906.08% in 2022.
  • GeneDx Holdings' Cash & Current Investments (Quarter) stood at $400.6 million in 2021, then tumbled by 69.06% to $123.9 million in 2022, then grew by 5.01% to $130.1 million in 2023, then rose by 8.48% to $141.2 million in 2024, then grew by 9.84% to $155.1 million in 2025.
  • Its Cash & Current Investments was $155.1 million in Q3 2025, compared to $134.6 million in Q2 2025 and $159.2 million in Q1 2025.